tiprankstipranks
Keros Therapeutics (KROS)
NASDAQ:KROS
US Market

Keros Therapeutics (KROS) Income Statement

Compare
309 Followers

Keros Therapeutics Income Statement

Last quarter (Q3 2024), Keros Therapeutics's total revenue was $388.00K, an increase of 4750.00% from the same quarter last year. In Q3, Keros Therapeutics's net income was $-52.96M. See Keros Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 151.00K$ 0.00$ 20.10M$ 0.00$ 10.00M
Gross Profit
$ -664.00K$ -1.61M$ 19.20M$ -605.00K$ -7.35M
Operating Expenses
$ 170.09M$ 107.71M$ 76.47M$ 44.20M$ 20.00M
Depreciation and Amortization
$ 815.00K$ 1.61M$ 898.00K$ 605.00K$ 438.00K
EBITDA
$ -152.18M$ -103.06M$ -56.37M$ -44.92M$ -11.89M
Operating Income
$ -169.94M$ -114.79M$ -56.37M$ -46.66M$ -10.56M
Other Income/Expenses
$ 16.95M$ 10.11M$ -360.00K$ 1.12M$ -1.77M
Pretax Income
$ -152.99M$ -104.68M$ -56.73M$ -45.53M$ -12.34M
Net Income
$ -152.99M$ -104.68M$ -58.74M$ -45.36M$ -12.34M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -5.20$ -4.15$ -2.52$ -2.93$ -1.39
Diluted EPS
$ -5.20$ -4.15$ -2.52$ -2.93$ -1.39
Weighted Average Shares Outstanding
29.45M 25.24M 23.33M 15.51M 8.88M
Weighted Average Shares Outstanding (Diluted)
29.45M 25.24M 23.33M 15.51M 8.88M
Currency in USD

Keros Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis